The Relationship between Third-generation TSH Receptor Antibody Positivity and Cumulative Methimazole Dose Used until Remission in Graves' Disease.

Ozçelik, Serhat; Celik, Mehmet; Vural, Aski; Aydin, Bunyamin; Gozu, Hulya

Ozçelik, Serhat; Celik, Mehmet; Vural, Aski; Aydin, Bunyamin; Gozu, Hulya.

Afiliação

Ozçelik S; Department of Endocrinology and Metabolic Diseases, University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital, Turkey.
Celik M; Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Trakya University Edirne, Turkey.
Vural A; Department of Internal Medicine, Adiyaman Training and Research Hospital, Turkey.
Aydin B; Department of Endocrinology and Metabolic Diseases, Adiyaman Training and Research Hospital, Turkey.
Gozu H; Marmara University Training and Research Hospital, Department of Endocrinology and Metabolism, Istanbul, Turkey.

J Coll Physicians Surg Pak ; 30(5): 517-522, 2021 May.

Article em En | MEDLINE | ID: mdl-34027861

Assuntos

Doença de Graves; Metimazol; Antitireóideos/uso terapêutico; Autoanticorpos; Estudos Transversais; Doença de Graves/tratamento farmacológico; Humanos; Imunoglobulinas Estimuladoras da Glândula Tireoide; Metimazol/uso terapêutico; Receptores da Tireotropina; Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Graves / Metimazol Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google